Australian PM Albanese and US President Trump discuss AUKUS and tariffs after Labor's historic election win.
Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
Henry Schein misses Q1 revenue, but KKR takes stake, influencing board composition amid operational challenges.
Australian PM Albanese and US President Trump discuss AUKUS and tariffs after Labor's historic election win.
Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
Henry Schein misses Q1 revenue, but KKR takes stake, influencing board composition amid operational challenges.